Oral isotretinoin: New safety measures following review into sexual and psychiatric adverse reactions
Direct Healthcare Professional Communication advises of the new safety measures for isotretinoin, as announced by the MHRA, following review into sexual and psychiatric adverse reactions. This includes the need for 2 independent prescribers to agree initiation in those <18 years.
Source:
Roche
SPS commentary:
The MHRA issued a Drug Safety Alert advising on the strengthened safety measures in October.